Balasa Dinverno & Foltz’s Shockwave Medical, Inc. Common Stock SWAV Stock Holding History

Balasa Dinverno & Foltz’s Portfolio SWAV Stock Details SWAV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q3	$461K	Buy	+1,659	New	+$422K	0.03%	209

Other funds holding SWAV

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

GGHC

Gilder Gagnon Howe & Co New York $8.34B AUM 46.58% 1-Year Est. Return

Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Balasa Dinverno & Foltz's SWAV Position: Q3 2022 in Review

Balasa Dinverno & Foltz opened a new position in Shockwave Medical, Inc. Common Stock (SWAV) in Q3 2022: 1,659 shares worth $461K. The stake represents 0.03% of the portfolio and ranks #209 among its holdings.

412 funds tracked by Wall St. Rank hold SWAV as of Q3 2022.

Balasa Dinverno & Foltz held 1,659 shares of Shockwave Medical, Inc. Common Stock worth $461K as of Q3 2022.
Shockwave Medical, Inc. Common Stock was a new Balasa Dinverno & Foltz position in Q3 2022.
Shockwave Medical, Inc. Common Stock made up 0.03% of Balasa Dinverno & Foltz's portfolio in Q3 2022, its #209 holding.
412 funds tracked by Wall St. Rank held Shockwave Medical, Inc. Common Stock as of Q3 2022.

Based on Balasa Dinverno & Foltz's 13F filing for Q3 2022, filed 25 Oct 2022.